Articles On Starpharma Holdings (ASX:SPL)

Starpharma (SPL) receives a $7.7 million research and development tax incentive refund The refund falls under the Australian Federal Government’s R&D Tax Incentive Scheme The funds were granted in relation to the company’s activities d...

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

Starpharma (ASX:SPL) has signed a commercial arrangement for its antiviral nasal spray Viraleze in Vietnam with orders in excess of 2 million since late October.

The Starpharma Holdings Ltd (ASX: SPL) share price is lifting this afternoon after a bumpy morning of trading. This follows the company release of a sales update today on an anti-viral product against COVID-19. At the time of writing, th...

Since October, pharmaceutical company Starpharma (SPL) has received VIRALEZE orders totalling more than $2 million for Vietnam On December 1, the company announced its nasal spray was registered for sale in Vietnam with a formal launch att...

The Starpharma Holdings Ltd (ASX: SPL) share price is soaring following the company announcement of a partnership agreement. At the time of writing, the dendrimer product developer’s shares are up 6.11% to $1.215 apiece. It’s worth noting...

The ASX 200 Health Index (XHJ) is down by 0.80% at the time of writing, compared to the broader index which is down by 0.40%. The stock price of Neuren Pharmaceuticals (ASX:NEU) is up 100% this morning after the company announced its North...

Starpharma (SPL) signs an exploratory Dendrimer Drug Delivery (DEP) research agreement with US Biopharma company, Genentech Genetech has an initial focus on evaluating DEP, dendrimer-based drug conjugates Starpharma’s dendrimer-based drug...

The Starpharma Holdings Limited (ASX: SPL) share price edged higher today following the launch of Viraleze in Vietnam this week. Viraleze is an antiviral nasal spray that has been shown to deactivate a broad spectrum of respiratory/cold vi...

03 Dec 2021 - Starpharam (ASX:SPL) has signed an ongoing agreement for the distribution of the VIRALEZE antiviral nasal spray in Vietnam.

The ASX 200 Health Index (XHJ) is down by 0.67% at the time of writing, compared to the broader index which is up by 0.47%. Alcidion Group (ASX:ALC) rose nearly 8% this morning, after revealing that it was a member of a consortium awarded a...

Starpharma (SPL) has signed an ongoing distribution arrangement to launch its VIRALEZE antiviral nasal spray in Vietnam The deal involves a minimum commitment of at least one million units of VIRALEZE in the first year, and will see the sp...

Starpharma’s (SPL) VIRALEZE antiviral nasal spray has been registered for sale in Vietnam The VIRALEZE product launch is scheduled to occur in Vietnam this week, with the product supplied under a supply distribution arrangement with Health...

The S&P/ASX 200 Index (ASX: XJO) is off its intraday lows but remains on course to start the month with a decline. In afternoon trade, the benchmark index is down 0.6% to 7,214.5 points. Four ASX shares that are not letting that hold t...

The Starpharma Holdings Limited (ASX: SPL) share price is racing ahead this morning after confirming its antiviral nasal spray will be launched in Vietnam this week. The biotech registered its VIRALEZE spray for sale in the Asian country....

The Starpharma Holdings Ltd (ASX: SPL) share price has gained more than 6% from the open today as investors respond positively to the company’s AGM. In the address, the biotech company outlined several investment takeouts, ranging from it...

Cancer diagnostics company Rhythm Biosciences Ltd (ASX:RHY) got a regulatory boost this morning, with news that CE Mark approval is now complete for its ColoSTAT blood test platform in the European market. Shares in the ~$350m company conti...

Aussie stocks were set to open higher following a tech-led rebound on Wall Street after President Joe Biden ruled out fresh lockdowns or travel restrictions to contain the Omicron Covid variant.   The Nasdaq bounced almost 1.9 per cent a...

Wall Street’s worst session in more than a year points to a challenging start to the Australian trading week as investors assess the risk from a new Covid variant.   Worrying reports about the virulence of the Omicron variant sent invest...

Shares in biotechnology company Starpharma Holdings Limited (ASX: SPL) ended this week with another day in the red, trading 0.97% down at $1.02 at Friday’s close. It’s been a lousy period for the company’s shareholders these past 3 months...

Starpharma (SPL) releases its September quarterly report, with the period again highlighted by the continued success of VIRALEZE In late July, VIRALEZE showed a reduction of more than 99.99 per cent against the Delta variant of SARS-CoV-2,...

The Starpharma Holdings Limited (ASX: SPL) share price is pushing higher today following an update from the biopharmaceutical company. At the time of writing, the dendrimer products developer’s shares are up 3.70% to $1.12. What did Starph...

Starpharma (SPL) pens an exclusive three-month deal to supply its VIRALEZE antiviral nasal spray in Vietnam, with 100,000 units due for delivery early next month Vietnam is experiencing a widespread outbreak of the COVID-19 Delta variant a...

Starpharma (ASX:SPL) has signed an initial supply contract for its VIRALEZE antiviral nasal spray in Vietnam with the first delivery expected in early November.

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to finish the week on a strong note. At the time of writing, the benchmark index is up 0.8% to 7,314.1 points. Four ASX shares that are climbing more than most today are...

The ASX 200 health stocks index (XHJ) had risen by 0.30% at the time of writing, compared to the broader ASX 200 index which is up by 0.74%. Immuron (ASX:IMC) jumped 19% this morning, after announcing a recent publication of the potential a...

The Starpharma Holdings Limited (ASX: SPL) share price is on course to end the week on a positive note. In morning trade, the dendrimer products developer’s shares are up 4.5% to $1.25. Why is the Starpharma share price rising? The catalys...

The S&P/ASX 200 index (ASX: XJO) has started the week on a downward trend, trading 0.36% lower today at 7251.1 points. At the same time, the S&P/ASX 200 Health Care index (XHJ) has also slipped 0.36% into the red from the opening...

Local markets looked brighter today. US share markets rebounded on Friday. Global oil prices also rose by around 1% on ahead of a meeting of OPEC+ producers today. Analysts expect that producers will add just 400,000 barrels per day in extr...

The Starpharma Holdings Ltd (ASX: SPL) share price is pushing higher today following a patent update from the biopharmaceutical company. At the time of writing, Starpharma shares are swapping hands for $1.385, up 5.73%. What did Starpharma...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is off its lows but still in the red. At the time of writing, the benchmark index is down 0.2% to 7,422.7 points. Four ASX shares that are not letting that hold them back are listed...

The Starpharma Holdings Limited (ASX: SPL) share price has dropped 2.76% this Thursday as the pharmaceutical company reported its earnings for the financial year ended 30 June 2021 (FY2021). Starpharma share price slumps as revenues fall,...

Highlights  The ASX200 closed 0.35% higher at 7,487.30, led by buying in tech, realty and consumer discretionary stocks. Mining firm Pilbara Minerals topped the gainer list, while insurance company NIB Holdings emerged as the top loser...

The ASX 200 finished lower for the second consecutive day, falling lower by 0.94% today as COVID-19 cases continue to rise in Australia and across the globe. Health Minister Greg Hunt however said that more than 10 million Australians have...

SYDNEY, Aug. 10, 2021 /PRNewswire/ — Monsido, a leading web governance provider, has released a benchmark report analysing the websites of the Top 30 Healthcare Organisations in Australia for their performance in Web Accessibility, Content...

The ASX 200 traded sideways today, and ended the day flat, rising just 2 points to 7,540. Financials led, rising by 1.4% following announcements from Suncorp (ASX:SUN) and NAB (ASX:NAB). Gold miners were the worst performers, as gold price...

The ASX200 chalked up another day of gains in Thursday trade, and once again it was resources leading the way. The ASX200 Materials index posted a solid 1.51% gain, and has now risen by at least 1% on five of the last seven trading days. Pr...

The winning streak for local stocks ran out of steam today, as all the major ASX200 indexes dipped into the red. After two straight days of >1% gains, the ASX200 Materials index (mining) dipped by around 0.70% in Wednesday trade. The ASX...

The Starpharma Holdings Limited (ASX: SPL) share price is deep in negative territory during early afternoon trade. This comes despite the healthcare company announcing an inclusion to its board. At the time of writing, Starpharma shares ar...

The ASX200 continued tracking a steady path forward, as the broader economy looks set to take a hit from Sydney’s ongoing COVID-19 troubles. Across sectors, the ASX200 indexes for both Resources and the Materials continued on their merry wa...

The ASX 200 touched intraday record highs, but could not hold on and closed the day just shy of its all time high. The benchmark index finished 0.46% higher at 7,428, and is now on track to finish July on a 10-month winning streak. Six out...

Listed pharmaceutical company Starpharma (ASX: SPL) has today doubled down on its anti-COVID nasal spray VIRALEZE, claiming lab tests done in the US show the product can help reduce the spread of the Delta strain of the virus.  "We are ve...

The Starpharma Holdings Limited (ASX: SPL) share price has been a strong performer on Tuesday morning. In early trade, the dendrimer products developer’s shares are up 7% to $1.35. Why is the Starpharma share price racing higher? Investors...

The ASX 200 edged 0.26% lower after trading flat at lunch time, despite stronger than expected employment numbers. All sectors were in the red, except for Utilities and Materials. Australia’s unemployment rate fell to 4.9%, with 29,100 jobs...

Summary The S&P/ASX200 ended 6.40 points higher at 7,315 ahead of the RBA policy decision due tomorrow. The index gained as much as 0.5% to hit an intraday high of 7,343.   Six of 11 sectors ended lower, while tech led the fall wi...

Summary Sydney Airport shares rose 38.38% to hit a 52-week high on receiving a takeover bid from infrastructure consortium. The share price of Starpharma dropped 8.7% after copping a fine from Australia’s medicines regulator for allege...

05 July 2021 - Starpharma (ASX:SPL) has received $93,240 worth of infringement notices from the Therapeutic Goods Administration.

Summary The S&P/ASX200 traded higher by 18.80 points or 0.26% at 7,327 by Monday afternoon. The index opened higher and gained as much as 0.5% to hit an intraday high of 7,343.   Seven of 11 sectors were trading higher, led by ind...

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX powerplays.   Theme of the week Healthcare...

Australian company Starpharma (ASX:SPL) has announced that the sale of its COVID-19 nasal spray in the UK has been temporarily halted following correspondence from this UK regulator related to promotional claims.